Arabica Coffee Prices Soar to Record High Amid USColombia Tariff Dispute Credit Suisse Analyst Projects Repo Rate to Hit Decade Low Signals Potential Market Rally from December US Stock Indices Rise on Renewed Hopes for Deescalation in Iran Tensions SpaceX Delays Starship Launch Amid Anticipated RecordBreaking Stock Market Debut IREN Expands Brand Strategy Through Acquisition of Awaken Micron Shares Rally After UBS Highlights Strong Memory Chip Demand and Enhanced LongTerm Agreements MFA Financial Inc 8875 Senior Notes due 2029 MFAN Q1 2026 Earnings Slight EPS Miss Amid Stable Bond Performance SRAD Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 VTEX Q1 2026 Earnings EPS Misses Estimates Stock Slides on Disappointing Profitability Wheeler Real Estate Investment Trust Inc Series D Cumulative Preferred Stock WHLRD Q2 2024 Earnings Preferred EPS Reported at 365 Stock Unchanged SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development Eikon Therapeutics Inc EIKN Slips 224 as Stock Holds Above Key Support Level CocaCola Consolidated COKE Faces Resistance as Shares Pull Back 223 Lineage Inc LINE Surges 2 as Stock Approaches Resistance Zone Pulse Biosciences PLSE Extends Gains as Positive Momentum Builds BNY Mellon High Yield Strategies Fund DHF Edges Higher Amid Stable Trading CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase ETOR Q1 2026 Earnings EPS Surges Past Estimates by 234 Revenue Details Remain Undisclosed WSBCO Q1 2026 Earnings Preferred EPS Surpasses Estimates by 321 Dianthus Therapeutics Q1 2026 Earnings EPS Beat Driven by Cost Discipline Yet Shares Slip Mister Car Wash MCW Q1 2026 Earnings EPS Surprise Beats Estimates Amid Steady Operations LEDS Q1 2026 Earnings Loss Per Share of 007 Amid Limited Disclosures Roth Capital Maintains Its Stance on T1 Energy Following Internal Discussion Hycroft Mining Holding Corporation HYMC Q3 2025 Earnings Narrower Loss Signals Progress in Cost Discipline ALX Oncology Slips 15 as Biotech Stock Tests Key Support at 183